Primer: Changchun BCHT Biotechnology C (688276 CH) - Aug 2026
Changchun BCHT Biotechnology is a key player in the Chinese vaccine market, with established products like its Varicella (chickenpox) vaccine,...
90 Views
RoboTechnik H Share Listing (3757 HK): The Investment Case
RoboTechnik makes manufacturing equipment for the PV and silicon photonics (SiPh) industries. It is seeking to raise up to US$663 million. In this...
115 Views
CanSino Biologics(6185 HK): Price Surged - Worth a Shot !!
CanSino Biologics (6185 HK)Â shares surged on the back of Moderna (MRNA US)Â breakthroughs with its mRNA vaccine for melanoma. Cansino was China's...
167 Views
China Healthcare Weekly (July.8)- CXO Outlook, 2022 NRDL Adjustment, Logic of Influenza Vaccine
CXO's prosperity may have problems in the next few years. We analyzed the logic. There is no long-term logic for influenza vaccine. A change in...
509 Views
China A-Shares:Â Biotechnology Exit
Allocations in Biotechnology stocks have taken a severe drop among active China A-Share investors. From a high of 4% in July of 2020, average fund...
435 Views